Showing 1 - 20 results of 32 for search 'Patrick N.A. Harris', query time: 0.08s Refine Results
  1. 1
    In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping review

    In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-res... by Abdullah Tarık Aslan, Yukiko Ezure, Juan Pablo Horcajada, Juan Pablo Horcajada, Juan Pablo Horcajada, Patrick N. A. Harris, Patrick N. A. Harris, David L. Paterson

    Published 2023-09-01
    Get full text
    Article
  2. 2
    Getting Up to Speed: Rapid Pathogen and Antimicrobial Resistance Diagnostics in Sepsis

    Getting Up to Speed: Rapid Pathogen and Antimicrobial Resistance Diagnostics in Sepsis by Mariana P. Liborio, Patrick N. A. Harris, Chitra Ravi, Adam D. Irwin

    Published 2024-09-01
    Get full text
    Article
  3. 3
    Long term sepsis readmission, mortality and cause of death following Gram negative bloodstream infection: a propensity matched observational linkage study

    Long term sepsis readmission, mortality and cause of death following Gram negative bloodstream infection: a propensity matched observational linkage study by John F. McNamara, Patrick N.A. Harris, Mark D. Chatfield, David L. Paterson

    Published 2022-01-01
    Get full text
    Article
  4. 4
    Epidemiology of <i>Aeromonas</i> Species Bloodstream Infection in Queensland, Australia: Association with Regional and Climate Zones

    Epidemiology of <i>Aeromonas</i> Species Bloodstream Infection in Queensland, Australia: Association with Regional and Climate Zones by Holly A. Sinclair, Felicity Edwards, Patrick N. A. Harris, Claire Heney, Kevin B. Laupland

    Published 2022-12-01
    Get full text
    Article
  5. 5
    Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales (“MERINO-3”): study protocol for a multicentre, open-label randomised non-inferiority trial

    Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales (“MERIN... by Adam G. Stewart, Patrick N. A. Harris, Mark D. Chatfield, Roberta Littleford, David L. Paterson

    Published 2021-04-01
    Get full text
    Article
  6. 6
    Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies

    Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta... by Anna Maria Peri, Weiping Ling, Luis Furuya-Kanamori, Patrick N. A. Harris, David L. Paterson

    Published 2022-10-01
    Get full text
    Article
  7. 7
    SG-APSIC1073: Incidence and predictors of Escherichia coli–producing extended-spectrum beta-lactamase (ESBL-Ec) in Queensland, Australia, from 2010 to 2019: A population-based spatial analysis

    SG-APSIC1073: Incidence and predictors of Escherichia coli–producing extended-spectrum beta-lactamase (ESBL-Ec) in Queensland, Australia, from 2010 to 2019: A population-based spat... by Weiping Ling, Angela Cadavid-Restrepo, Luis Furuya-Kanamori, Patrick N.A. Harris, David L. Paterson

    Published 2023-02-01
    Get full text
    Article
  8. 8
    Morganella morganii, an Emerging Cause of Bloodstream Infections

    Morganella morganii, an Emerging Cause of Bloodstream Infections by Kevin B. Laupland, David L. Paterson, Felicity Edwards, Adam G. Stewart, Patrick N. A. Harris

    Published 2022-06-01
    Get full text
    Article
  9. 9
    Sphingomonas paucimobilis bloodstream infection is a predominantly community-onset disease with significant lethality

    Sphingomonas paucimobilis bloodstream infection is a predominantly community-onset disease with significant lethality by Kevin B. Laupland, David L. Paterson, Adam G. Stewart, Felicity Edwards, Patrick N.A. Harris

    Published 2022-06-01
    Get full text
    Article
  10. 10
    Current and Emerging Treatment Options for Multidrug Resistant <i>Escherichia coli</i> Urosepsis: A Review

    Current and Emerging Treatment Options for Multidrug Resistant <i>Escherichia coli</i> Urosepsis: A Review by Mikaela M. Walker, Jason A. Roberts, Benjamin A. Rogers, Patrick N. A. Harris, Fekade B. Sime

    Published 2022-12-01
    Get full text
    Article
  11. 11
    Mortality, hospital length of stay, and recurrent bloodstream infections associated with extended-spectrum beta-lactamase-producing Escherichia coli in a low prevalence region: A 20-year population-based large cohort study

    Mortality, hospital length of stay, and recurrent bloodstream infections associated with extended-spectrum beta-lactamase-producing Escherichia coli in a low prevalence region: A 2... by Weiping Ling, David L. Paterson, Patrick N.A. Harris, Luis Furuya-Kanamori, Felicity Edwards, Kevin B. Laupland

    Published 2024-01-01
    Get full text
    Article
  12. 12
    The global epidemiology of ventilator-associated pneumonia caused by multi-drug resistant Pseudomonas aeruginosa: A systematic review and meta-analysis

    The global epidemiology of ventilator-associated pneumonia caused by multi-drug resistant Pseudomonas aeruginosa: A systematic review and meta-analysis by Yixuan Li, Jason A. Roberts, Mikaela M. Walker, Abdullah Tarik Aslan, Patrick N.A. Harris, Fekade B. Sime

    Published 2024-02-01
    Get full text
    Article
  13. 13
    In Vitro Activity of Cefotetan against ESBL-Producing Escherichia coli and Klebsiella pneumoniae Bloodstream Isolates from the MERINO Trial

    In Vitro Activity of Cefotetan against ESBL-Producing Escherichia coli and Klebsiella pneumoniae Bloodstream Isolates from the MERINO Trial by Adam G. Stewart, Kyra Cottrell, Andrew Henderson, Kanthi Vemuri, Michelle J. Bauer, David L. Paterson, Patrick N. A. Harris

    Published 2021-09-01
    Get full text
    Article
  14. 14
    Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case–control study

    Risk factors for relapse or persistence of bacteraemia caused by Enterobacter spp.: a case–control study by Patrick N. A. Harris, Anna M. Peri, Anita M. Pelecanos, Carly M. Hughes, David L. Paterson, John K. Ferguson

    Published 2017-01-01
    Get full text
    Article
  15. 15
    Budget impact analysis of routinely using whole-genomic sequencing of six multidrug-resistant bacterial pathogens in Queensland, Australia

    Budget impact analysis of routinely using whole-genomic sequencing of six multidrug-resistant bacterial pathogens in Queensland, Australia by Philip L Russo, David L Paterson, Thomas M Elliott, Louisa G Gordon, Brian Forde, Brett Mitchell, Patrick N A Harris

    Published 2021-02-01
    Get full text
    Article
  16. 16
    Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trial

    Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study pr... by Hugh Wright, Patrick N. A. Harris, Mark D. Chatfield, David Lye, Andrew Henderson, Tiffany Harris-Brown, Anna Donaldson, David L. Paterson

    Published 2021-12-01
    Get full text
    Article
  17. 17
    Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae.

    Empiric Piperacillin-Tazobactam versus Carbapenems in the Treatment of Bacteraemia Due to Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae. by Tat Ming Ng, Wendy X Khong, Patrick N A Harris, Partha P De, Angela Chow, Paul A Tambyah, David C Lye

    Published 2016-01-01
    Get full text
    Article
  18. 18
    Non-inferiority trial of a shorter (7 days) compared with a longer (14 days) duration of antimicrobial therapy for the treatment of bacteraemic urinary sepsis, measured by microbiological success after the completion of therapy: a substudy protocol for the Bacteraemia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE) multicentre randomised controlled trial

    Non-inferiority trial of a shorter (7 days) compared with a longer (14 days) duration of antimicrobial therapy for the treatment of bacteraemic urinary sepsis, measured by microbio... by Nick Daneman, Asgar Rishu, Robert Fowler, Ruxandra L Pinto, Yahya Shehabi, Patrick N A Harris, Benjamin A Rogers, Joshua S Davis, Dhiraj Bhatia Dwivedi

    Published 2023-06-01
    Get full text
    Article
  19. 19
    <i>Achromobacter</i> Species: An Emerging Cause of Community-Onset Bloodstream Infections

    <i>Achromobacter</i> Species: An Emerging Cause of Community-Onset Bloodstream Infections by Burcu Isler, David L. Paterson, Patrick N. A. Harris, Weiping Ling, Felicity Edwards, Claire M. Rickard, Timothy J. Kidd, Ian Gassiep, Kevin B. Laupland

    Published 2022-07-01
    Get full text
    Article
  20. 20
    Using Genomics To Investigate an Outbreak of Vancomycin-Resistant Enterococcus faecium ST78 at a Large Tertiary Hospital in Queensland

    Using Genomics To Investigate an Outbreak of Vancomycin-Resistant Enterococcus faecium ST78 at a Large Tertiary Hospital in Queensland by Budi Permana, Patrick N. A. Harris, Naomi Runnegar, Margaret Lindsay, Belinda C. Henderson, E. G. Playford, David L. Paterson, Scott A. Beatson, Brian M. Forde

    Published 2023-06-01
    Get full text
    Article

Search Tools: